1. Zawadzki J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Blackwell Scientific; 1995: 377-384.
2. Petry C, Ong K, Michelmore K. Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Hum Reprod 2005; 20: 1837-1843. [
DOI:10.1093/humrep/deh900]
3. Yildiz B, Yarali H, Bayaraktar M. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 2031-2036. [
DOI:10.1210/jc.2002-021499]
4. Williamson K, Gunn A, Johnson N, Milson S. The impact of ethnicity on the presentation of polycystic ovarian syndrome. Aust N Z J Obs Gynaecol 2001; 41: 202-206. [
DOI:10.1111/j.1479-828X.2001.tb01210.x]
5. Gaasenbeek M, Powell B, Sovio U, Haddad L. Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. J Clin Endocrinol Metab 2004; 89: 2408-2413. [
DOI:10.1210/jc.2003-031640]
6. Diamanti-Kandarakis E, Bartzis M, Zapanti E. Polymorphism T→C (34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Fertil Steril 1999; 71: 431-435. [
DOI:10.1016/S0015-0282(98)00512-3]
7. Jones M, Italiano L, Wilson S, Mullin B. Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome. Fertil Steril 2006; 86: 1438-1446. [
DOI:10.1016/j.fertnstert.2006.04.027]
8. Jin L, Zhu X, Luo Q, Qian Y. A novel SNP at exon 17 of INSR is associated with decreased insulin sensitivity in Chinese women with PCOS. Mol Hum Reprod 2006; 3: 151-155. [
DOI:10.1093/molehr/gal022]
9. Gharani N, Waterworth D, Batty S. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 1997; 6: 397-402. [
DOI:10.1093/hmg/6.3.397]
10. Bulun S, Takayama K, Suzuki T, Sasano H, Yilmaz B, Sebastian S. Organization of the human aromatase p450 (CYP19) gene. Semin Reprod Med 2004; 22: 5-9. [
DOI:10.1055/s-2004-823022]
11. Dhatariya K, Nair K. Dehydroepiandrosterone: is there a role for replacement? Mayo Clin Proc 2003; 78: 1257-1273. [
DOI:10.4065/78.10.1257]
12. Guo Y, Xiong D, Yang T. Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females. Hum Mol Genet 2006; 15: 2401-2408. [
DOI:10.1093/hmg/ddl155]
13. Bulun S, Sebastian S, Takayama K, Suzuki T, Sasano H, Shozu M. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol 2003; 86: 219-224. [
DOI:10.1016/S0960-0760(03)00359-5]
14. Meinhardt U, Mullis P. The essential role of the aromatase/p450arom. Semin Reprod Med 2002; 20: 277-283. [
DOI:10.1055/s-2002-35374]
15. Sowers M, Wilson A, Kardia S, Chu J, Ferrel R. Aromatase Gene (CYP 19) Polymorphisms and Endogenous Androgen Concentrations in a Multiracial/Multiethnic, Multisite Study of Women at Midlife. Am J Med 2006; 119: 23-30. [
DOI:10.1016/j.amjmed.2006.07.003]
16. Xita N, Lazaros L, Georgiou I, Tsatsoulis A. CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype. Fertil Steril 2010; 94: 250-254. [
DOI:10.1016/j.fertnstert.2009.01.147]
17. Jin J, Sun J, Ge H, Cao Y. Association between CYP19 gene SNP rs2414096 Polymorphism and polycystic ovary syndrome in Chinese women. BMC Med Genet 2009; 10: 139. [
DOI:10.1186/1471-2350-10-139]
18. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25. [
DOI:10.1016/j.fertnstert.2003.10.004]
19. Yu Y, Sun C, Liu Y, Li Y, Wang L, Zhang W. Promoter methylation of CYP19A1 gene in Chinese polycystic ovary syndrome patients. Gynecol Obstet Invest 2013; 76: 209-213 [
DOI:10.1159/000355314]
20. Xu P, Zhang XL, Xie GB, Zhang CW, Shen SM, Zhang XX, et al. The (TTTA) n polymorphism in intron 4 of CYP19 and the polycystic ovary syndrome risk in a Chinese population. Mol Biol Rep 2013; 40: 5041-5047. [
DOI:10.1007/s11033-013-2605-4]
21. Zhang X, Zhang C, Xu P, Liang F. SNP rs2470152 in CYP19 is correlated to aromatase activity in Chinese polycystic ovary syndrome patients. Mol Med Rep 2012; 5: 245-249.
22. Ghasemi N, Mortazavizadeh MR, Khorasani Gerdekoohi A. Frequency of poly cystic ovary syndrome in patients with premenopausal breast cancer. Int J Reprod Biomed 2010; 8: 86-89.
23. Mehdizadeh A, Sheikhha MH, Kalantar SM, Aali BS, Ghanei A. Mutation analysis of exon1 of bone morphogenetic protein-15 gene in Iranian patients with polycystic ovarian syndrome. Int J Reprod Biomed 2016; 14: 527-532.